How 'hypermutated' malignant brain tumors escape chemotherapy and immunotherapy
Wednesday, April 15, 2020 - 22:30
in Health & Medicine
An analysis of more than 10,000 gliomas and clinical outcomes found that glioma patients whose tumors were hypermutated actually had no significant benefit when treated with checkpoint blockers.